Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Hepatitis B vaccination: a cost analysis.

Bergus G, Meis S.

Iowa Med. 1995 May;85(5):209-11. No abstract available.

PMID:
7607831
2.

[Cost-benefit analysis on immunization of newborns with hepatitis B vaccine in Jinan City].

Liu ZG, Zhao SL, Zhang YX.

Zhonghua Liu Xing Bing Xue Za Zhi. 1995 Apr;16(2):81-4. Chinese.

PMID:
7781052
3.

Cost-benefit analysis of the Polish hepatitis B prevention programme.

WiewiĆ³ra-Pilecka D.

Vaccine. 2000 Feb 18;18 Suppl 1:S52-4.

PMID:
10683548
4.

Universal hepatitis B vaccination: the economics of prevention.

Krahn MD, Detsky AS.

CMAJ. 1992 Jan 1;146(1):19-21. No abstract available.

5.

[The use of decision making analysis for evaluating hepatitis B inoculation strategy].

Zhuang GH, Xu HW.

Zhonghua Yu Fang Yi Xue Za Zhi. 1993 Mar;27(2):69-73. Chinese.

PMID:
8354107
6.

[The costs of hepatitis B vaccination: a re-evaluation].

van de Ven AA, van Hattum J, Willers JM.

Ned Tijdschr Geneeskd. 1990 Feb 10;134(6):298-301. Dutch. No abstract available.

PMID:
2137560
7.

Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early?

Ganiats TG, Bowersox MT, Ralph LP.

J Fam Pract. 1993 Feb;36(2):147-9. No abstract available.

PMID:
8426132
8.

Cost-benefit analysis of the introduction of mass vaccination against hepatitis B in Italy.

Johnstone T.

J Public Health Med. 1993 Sep;15(3):289-90. No abstract available.

PMID:
8251212
9.

A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.

Bloom BS, Hillman AL, Fendrick AM, Schwartz JS.

Ann Intern Med. 1993 Feb 15;118(4):298-306.

PMID:
8420448
10.

[Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].

Wu GY, Gong YL, Yu SL, Shao RT, Qin HJ.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jun;25(6):474-8. Chinese.

PMID:
15231120
11.

Hepatitis B vaccine: should we give it a shot?

Dickinson CJ, Olson A.

Hepatology. 1993 Aug;18(2):458-60. No abstract available.

PMID:
8340077
12.

Hepatitis B in Australia: on course for universal vaccination.

Goldwater PN.

Med J Aust. 1996 Sep 16;165(6):300-1. No abstract available.

PMID:
8862325
13.

Control of hepatitis B: to be or not to be?

Hall CB, Halsey NA.

Pediatrics. 1992 Aug;90(2 Pt 1):274-7. No abstract available.

PMID:
1386421
14.

Cost-effectiveness of hepatitis A and B vaccination programme in Germany.

Szucs T.

Vaccine. 2000 Feb 18;18 Suppl 1:S86-9.

PMID:
10683559
15.

Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.

Kim SY, Billah K, Lieu TA, Weinstein MC.

Am J Prev Med. 2006 Jun;30(6):498-506.

PMID:
16704944
16.

[Studies on immunization strategies for hepatitis B in different endemic areas of China].

Wang L, Li H, Wang S, Gong J, Zeng X, Li R, Nong Y, Huang Y, Chen X, Huang Z.

Zhonghua Yu Fang Yi Xue Za Zhi. 1999 Mar;33(2):104-6. Chinese.

PMID:
11864465
17.

Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.

Tilson L, Thornton L, O'Flanagan D, Johnson H, Barry M.

Eur J Public Health. 2008 Jun;18(3):275-82. Epub 2007 Dec 26. Erratum in: Eur J Public Health. 2008 Dec;18(6):693.

19.

[Cost-benefit analysis of vaccinal prevention of hepatitis B policy].

Kerleau M, Flori YA, Nalpas B, LanoƩ JL, Berthelot P, Fardeau-Gautier M.

Rev Epidemiol Sante Publique. 1995;43(1):48-60. French.

PMID:
7892516
20.

Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.

Jacobs RJ, Rosenthal P, Meyerhoff AS.

Vaccine. 2004 Mar 12;22(9-10):1241-8.

PMID:
15003653
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk